Agilus Diagnostics Limited IPO

The company recently changed its brand which led to certain legal proceedings that are currently pending before the Delhi High Court. Any unfavorable outcome may have an adverse effect on its business, reputation, results of operations and financial condition.

Any failure to establish its new brand may adversely affect customer confidence in the company services or its inability to maintain and enhance its brand and reputation or any negative publicity and allegations, may have an adverse impact on its business, reputation, results of operations and financial condition.

Its trade mark applications in relation to its new brand, "Agilus Diagnostics" and "Agilus" are not yet registered, and some have been objected/ opposed by other parties. Any inability to obtain registration or otherwise protect its intellectual property rights, or any exposure to misappropriation and infringement claims by third parties, could have an adverse effect on its business, reputation, financial condition and results of operations.

Its Promoter, Fortis Healthcare Limited, is subject to certain regulatory and statutory proceedings, including an appeal pending before the Securities Appellate Tribunal and an ongoing investigation by the Serious Fraud Investigation Office for certain alleged improper transactions and non-compliance with applicable laws and regulations including the Companies Act. Any prolonged proceedings or adverse outcome of such proceedings in the future may have an adverse impact on its business and reputation.

There are outstanding litigation against the Company, Promoter, Directors, Group Companies and Subsidiaries. An adverse outcome in any of these proceedings may affect its reputation and standing and impact its future business and could have a material adverse effect on its business, results of operations, financial condition and cash flows.

The company is liable to protect its patients' personal information and any failure to protect such information, could materially and adversely affect its business, results of operations and financial condition.

The company is subject to various operational, reputational, medical and legal claims, regulatory actions or other liabilities arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could adversely affect its business, results of operations and financial condition.

Its industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labor and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, results of operations and financial condition.

The company currently avail tax benefits and are entitled to certain incentives. Any change in these benefits and incentives applicable to it or a delay in disbursement of benefits under such schemes may affect its results of operations.

The company has entered into a master service agreement with its Promoter and certain other letters/ agreements with its Promoter and its affiliates in respect of providing certain laboratory management services to them and are dependent on them for a portion of its revenues. Any non-performance, non-renewal/ revision, substantial change in the agreed rates or termination of such agreements may adversely affect its business, results of operations and financial condition.